Quidel Corp. (QDEL) Stock Price Up 1.3%
Shares of Quidel Corp. (NASDAQ:QDEL) rose 1.3% during trading on Wednesday . The stock traded as high as $21.93 and last traded at $21.84, with a volume of 64,475 shares. The stock had previously closed at $21.55.
QDEL has been the subject of several analyst reports. Zacks Investment Research downgraded Quidel Corp. from a “buy” rating to a “hold” rating in a research note on Saturday, July 23rd. Canaccord Genuity reaffirmed a “hold” rating and set a $22.00 price target on shares of Quidel Corp. in a research report on Friday, July 29th. TheStreet downgraded Quidel Corp. from a “hold” rating to a “sell” rating in a research report on Friday, May 6th. Finally, Raymond James Financial Inc. raised Quidel Corp. from a “market perform” rating to an “outperform” rating and set a $21.50 price target for the company in a research report on Monday, June 13th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $21.58.
The stock has a 50 day moving average price of $21.34 and a 200-day moving average price of $18.06. The stock’s market capitalization is $692.22 million.
Quidel Corp. (NASDAQ:QDEL) last announced its earnings results on Wednesday, July 27th. The company reported ($0.11) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.25) by $0.14. The business earned $39.10 million during the quarter, compared to analyst estimates of $37.98 million. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter last year, the business posted ($0.14) earnings per share. On average, analysts predict that Quidel Corp. will post ($0.14) EPS for the current fiscal year.
In related news, SVP John Tamerius sold 7,000 shares of the firm’s stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $23.02, for a total value of $161,140.00. Following the transaction, the senior vice president now owns 18,540 shares in the company, valued at $426,790.80. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Robert Joseph Bujarski sold 22,057 shares of the firm’s stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $22.58, for a total value of $498,047.06. Following the completion of the transaction, the senior vice president now owns 60,100 shares in the company, valued at approximately $1,357,058. The disclosure for this sale can be found here.
A hedge fund recently raised its stake in Quidel Corp. stock. Schwab Charles Investment Management Inc. boosted its stake in shares of Quidel Corp. (NASDAQ:QDEL) by 11.2% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 99,410 shares of the company’s stock after buying an additional 10,002 shares during the period. Schwab Charles Investment Management Inc. owned 0.30% of Quidel Corp. worth $2,108,000 as of its most recent SEC filing.
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company’s diagnostic testing solutions primarily include applications in infectious diseases, women’s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers.